ArticleMolecular and clinical oncology2022

Tissue factor pathway inhibitor 2 as a serum marker for diagnosing asymptomatic venous thromboembolism in patients with epithelial ovarian cancer and positive D-dimer results.

Ryuta Miyake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.